PeptideStack
5.2kquestions
20kanswers
220users

What degradation pathway dominates at 25 °C in solution?

Asked 23 Sept 2025Modified 8 months agoViewed 8.8k times
22

The vial was lyophilised at the time, which I understand may matter a great deal.

I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious.

My background is quantitative but not chemical, so I can follow an equation more easily than a hand-wave.

Is the standard explanation correct, and if so, what is the evidence for it?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

503 questions
shareeditfollowflag
YM
askedyuki_morishita10k1423 Sept 2025
3Same question here after a warm delivery, so I am following this. – k_szabo 4 months ago
4Worth saying whether the vial has been opened, because that starts a different clock. – tobias_maartens 6 months ago
add a comment

3 Answers

Accepted answer first, then by votes
89

Accepted answer

25 °C is 20 kelvin above the 5 °C middle of a 2–8 °C refrigerator, which the ten-degree rule of thumb makes about 4 times the refrigerated rate — but the rule averages every route at once, and it is the ranking that changes with temperature, not just the speed. In aqueous solution at 25 °C the chemical routes that lead are deamidation at Asn, which proceeds through a succinimide and leaves a product one dalton heavier, and hydrolysis of the backbone, which leaves a mass ladder of shorter fragments. Both are strongly pH-dependent, and deamidation accelerates sharply above pH 7. Running alongside them is a physical route with no covalent change at all: association and aggregation, driven by the air-liquid interface rather than by temperature, and largely invisible to a reversed-phase method because the run is performed in organic solvent. So the honest answer is that at 25 °C deamidation usually leads on a chemical assay while aggregation leads on a plate that has been shaken, and which one you find is partly a statement about which method you chose. 4 times a refrigerated rate is an order-of-magnitude statement about a rate, not a shelf life. Reconstituted material has no certificate; the one in the box describes the powder.

Start with the sequence, because which pathways are available depends on which residues are present.

Aggregation is physical: peptides unfold at air-liquid interfaces and associate. Shaking maximises that interface, which is why swirling and shaking produce visibly different outcomes on the same vial.

It helps to be literal here: deamidation converts asparagine or glutamine to the corresponding acid via a succinimide intermediate, adding one dalton. It is base-catalysed, accelerates above neutral pH and is the dominant aqueous pathway for many peptides.

Metal-catalysed oxidation of methionine is documented across peptide and protein formulations and is why chelators appear in some formulations.

Sequence decides which pathways are even available. Check the residues.

shareimprove this answerflag
FC
answered · acceptedforty_two_c66k5830 Oct 2025
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
34

Asparagine and glutamine are the deamidation risk, and methionine is the oxidation risk.

A mass spectrum resolves most of this: minus eighteen is dehydration or succinimide, plus one is deamidation, plus sixteen is oxidation, and an unchanged mass with a shifted retention time is an isomer.

In practice, freeze-thaw cycling drives aggregation through concentration at the ice interface and pH shifts as buffer components crystallise out at different rates. Each cycle costs something.

Adsorption losses at low concentrations are quantified in formulation studies and are the reason carrier proteins are used in dilute preparations.

Nothing here is medical advice, and research-use compounds are not approved for human use.

A mass spectrum names the pathway. Plus one, plus sixteen, minus eighteen.

shareimprove this answerflag
DB
answeredDr_Fatima_Belkacem18k2611 Nov 2025
-2

Answering this needs the physical state, since a dry powder is protected from most of these and a solution is protected from none.

Oxidation targets methionine, cysteine and tryptophan, adding sixteen daltons per oxygen. It is catalysed by trace metals and promoted by dissolved oxygen and by light.

Hydrolysis cleaves the backbone, most readily at aspartate-proline and aspartate-glycine sequences, and is acid-catalysed. In a dry solid it barely proceeds at all.

Apparent loss in a dilute preparation is usually adsorption rather than degradation and is worth ruling out first.

At dilute concentrations, suspect adsorption before you suspect chemistry.

edited 7 Dec 2025 by marta_okonkwo — added a caveat about sampling

shareimprove this answerflag
MO
answeredmarta_okonkwo190k25822 Nov 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.